Abstract
Provided herein are compounds and compositions thereof that reduce WEE1 kinase protein levels. In some embodiments, the compounds and compositions are provided for treatment of WEE1 associated diseases such as cancer. In some embodiments, the compound is a compound according to Formula (I) or a pharmaceutically acceptable salt, tautomer, isotopologue, or stereoisomer thereof.